Stock code: 000963 Stock abbreviation: Huadong Medicine Announcement No.: 2023-028
Huadong Medicine Co., Ltd.
First Quarterly Report 2023
The Company and all members of the Board of Directors hereby guarantee that the information
presented in this report is authentic, accurate and complete and free of any false records, misleading
statements or material omissions.
Important Declaration:
1. The Board of Directors, Board of Supervisors, directors, supervisors and senior management of Huadong
Medicine Co., Ltd. (hereinafter referred to as the “Company”) hereby guarantee that the information presented in
this report is authentic, accurate and complete and free of any false records, misleading statements or material
omissions, and shall undertake individual and joint legal liabilities.
2. TheCompany’slegalrepresentative,theofficerinchargeofaccounting,andtheheadofaccountingdepartment
(accounting supervisor) hereby declare that the financial information in this quarterly report is authentic, accurate
and complete.
3. Has the First Quarterly Report been audited
□ Yes No
According to “Stock Listing Rules of the Shenzhen Stock Exchange”, if listed companies have both Chinese and
other language version of public notice, they should ensure the content of both versions are the same. In the case of
discrepancy, the original version in Chinese shall prevail.
I. Key Financial Data
(I) Key accounting data and financial indicators
Is the Company required to adjust or restate retroactively the accounting data in previous years
□ Yes No
Increase/decrease for the
For the reporting period For the same period last year reporting period as compared
with the same period last year
(%)
Operating income (CNY) 10,114,531,331.77 8,932,579,251.75 13.23%
Net profit attributable to
shareholders of the listed 755,284,976.47 704,364,775.13 7.23%
company (CNY)
Net profit attributable to
shareholders of the listed 757,542,618.01 698,524,004.62 8.45%
company after deducting non-
recurring profit or loss (CNY)
Net cash flow from operating -246,152,770.16 -260,603,628.32 5.55%
activities (CNY)
Basic earnings per share 0.4316 0.4025 7.23%
(CNY/per share)
Diluted earnings per share 0.4315 0.4025 7.20%
(CNY/share)
Weighted average return on 3.99% 4.17% -0.18%
equity (ROE)
Increase/decrease as at the
As at the end of the reporting As at the end of last year end of the reporting period as
period compared with the end of last
year (%)
Total assets (CNY) 32,115,200,767.26 31,192,203,406.84 2.96%
Owners' equity attributable to
shareholders of the listed 19,314,073,760.97 18,577,919,237.39 3.96%
company (CNY)
Total share capital of the Company as at the trading date prior to disclosure:
Total share capital of the Company as at the trading date prior 1,753,995,348.00
to disclosure (shares)
Fully diluted earnings per share calculated with the latest share capital:
Preferred stock dividends paid (CNY) 0.00
Interest on perpetual bonds paid (CNY) 0.00
Fully diluted earnings per share calculated with the latest share 0.4306
capital (CNY/share)
(II) Non-recurring profit or loss items and amounts
Applicable □ Not applicable
Unit: CNY
Item For the reporting period Description
Profit or loss from disposal of non-
current assets (including the written-off -2,020,270.17
portion for which provision for
impairment of
查看PDF原文
